High-Throughput Screening of Glycan Derivatives

High-Throughput Screening of Glycan Derivatives

Importance of High-Throughput Screening (HTS) for The Screening of Glycan Derivatives

Glycan derivatives are compounds derived from monosaccharide molecules through chemical modifications or chemical changes. These derivatives include polysaccharides, oligosaccharides, glycoproteins, glycolipids, etc. They have vital physiological functions, such as supplying energy to cells and participating in processes such as cell signaling and protein folding. Automated equipment is often used to speed up the sample preparation and analysis process, making screening more efficient. While traditional screening methods for glycosyl derivatives are time-consuming and labor-intensive, high-throughput screening techniques allow for the simultaneous testing of a large number of samples in a shorter period of time, accelerating the drug discovery process and improving efficiency. In the HTS of glycan derivatives, the HTS platforms allow the handling of multiple samples simultaneously and provide efficient liquid handling and analytical tools to determine their effect on specific biological activities.

HTS of Glycan Derivatives at CD BioGlyco

CD BioGlyco has extensive experience in screening and analysis of glycan derivatives and has accumulated rich data resources and experimental techniques. We provide HTS of glycan derivatives to help you efficiently screen out target molecules and provide more reliable support for your glycobiology research. Our HTS services include but are not limited to:

Advantages of Us

  • Visualization analysis
  • Fast and accurate analysis of large numbers of samples
  • Adapting experimental details to customer research needs


  • Development of antiviral, antibacterial, and antitumor drugs, etc.
  • Screening of sugar derivatives with functional effects
  • Development of sugar-based vaccines

CD BioGlyco offers HTS of glycan derivatives that enable rapid and accurate activity screening of target molecules, thus providing comprehensive experimental support for your research and development projects. If you are interested in our services, please contact us for more detailed information.


  1.  Primack, J.; et al. A high‐throughput microchip‐based glycan screening assay for antibody cell culture samples. Electrophoresis. 2011, 32(10): 1129-1132.
  2. Yang, X.; et al. Ultrafast and high-throughput N-glycan analysis for monoclonal antibodies. MAbs. Taylor & Francis. 2016, 8(4): 706-717.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.